Comprehensive bioinformatics analysis reveals potential lncRNA biomarkers for overall survival in patients with hepatocellular carcinoma: an on-line individual risk calculator based on TCGA cohort

Abstract

Background Accumulated evidences have demonstrated that long non-coding RNAs (lncRNAs) are correlated with prognosis of patients with hepatocellular carcinoma. The current study aimed to develop and validate a prognostic lncRNA signature to improve the prediction of overall survival in hepatocellular carcinoma patients. Methods The study cohort involved 348 hepatocellular carcinoma patients with lncRNA expression information and overall survival information. Through gene mining approach, the current study established a prognostic lncRNA signature (named LncRNA risk prediction score) for predicting the overall survival of hepatocellular carcinoma patients. Results The current study built a predictive nomogram based on ten prognostic lncRNA predictors through Cox regression analysis. In model group, the Harrell’s concordance indexes of LncRNA risk prediction score were 0.811 (95% CI 0.769–0.853) for 1-year overall survival, 0.814 (95% CI 0.772–0.856) for 3-year overall survival and 0.796 (95% CI 0.754–0.838) for 5-year overall survival respectively. In validation cohort, the Harrell’s concordance indexes of LncRNA risk prediction score were 0.779 (95% CI 0.737–0.821), 0.828 (95% CI 0.786–0.870) and 0.796 (95%CI 0.754–0.838) for 1-year survival, 3-year survival and 5-year survival respectively. LncRNA risk prediction score could stratify hepatocellular carcinoma patients into low risk group and high risk group. Further survival curve analysis demonstrated that the overall survival rate of high risk patients was significantly poorer than that of low risk patients ( P < 0.001). Conclusions In conclusion, the current study developed and validated a prognostic signature to predict the individual mortality risk for hepatocellular carcinoma patients. LncRNA risk prediction score is helpful to identify the patients with high mortality risk and optimize the individualized treatment decision. The web calculator can be used by click the following URL: https://zhangzhiqiao2.shinyapps.io/Smart_cancer_predictive_system_HCC_3/ . Electronic supplementary material The online version of this article (10.1186/s12935-019-0890-2) contains supplementary material, which is available to authorized users.

Low expression of long noncoding RNA CTC‐297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma

“…Recent research pointed out that lncRNA CTC‐297N7.9 was differentially expressed in HCC and normal liver tissues. According to the TCGA database, its expression is significantly associated with the survival of HCC patients . CTC‐297N7.9 was also reported to participate in the construction of prognostic models that identified the role of lncRNA as a protective factor in HCC .…”

Bioinformatics Identified 17 Immune Genes as Prognostic Biomarkers for Breast Cancer: Application Study Based on Artificial Intelligence Algorithms

“…Several prognostic models have been built for predicting the prognosis in BC patients (11)(12)(13). The previous prognosis models could only provide the mortality curves for two groups of tumor patients with different characteristics, failing to provide the individual mortality curve for a special patient.…”

“…Immune-related genes could be used to calculate the immune scores and evaluate the tumor infiltration of immune cells to analyze the tumor immune characteristics (10). There were several prognostic models for prediction of prognosis in BC patients (11)(12)(13). However, these prognostic models could only provide mortality risk prediction for patients in different subgroups, but not individual mortality risk prediction for a specific patient at the individual level.…”

Immune gene prognostic signature for disease free survival of gastric cancer Translational research of an artificial intelligence survival predictive system

“…Precision medical predictive tools can provide individualized mortality risk prediction and help clinicians early identify patients with high mortality risk. Recently, our team has successfully developed several precision medical predictive tools based on genetic data for different tumors [18][19][20]. In recent years, the development of arti cial intelligence algorithms provides more choices for the predictive studies of tumor prognosis.…”